Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
First human test for new pain pill begins
Knowledge-focused Recruiting nowThis is the first-ever study of a new pain medication called GRT7041 in people. It aims to check if the drug is safe and how the body handles it. The study will involve about 70 healthy volunteers who will take single or multiple doses. Researchers will closely monitor for side e…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
First human test for new DMD drug begins
Knowledge-focused Recruiting nowThis is a very early study to check if a new drug called GRT6019 is safe for people. It will be given to 24 healthy male volunteers for four weeks to see how their bodies react and process it. The main goal is to find the right dose and understand side effects before testing in p…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated Feb 27, 2026 15:18 UTC